Postprandial serum induces apoptosis in endothelial cells: Role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity.
Postprandial state is a pro-inflammatory condition associated with a transient impairment of endothelial function. Recent evidence suggests that myeloperoxidase (MPO) and matrix metalloproteinase-9 (MMP-9) are involved in the pathogenesis of inflammatory vascular diseases such as atherosclerosis. The present study was carried out to investigate whether a fat meal induces polymorphonuclear (PMN) activation and increases the plasma activity of MPO and MMP-9 and whether postprandial serum exerts pro-apoptotic effects on endothelial cells. Fifteen healthy young men underwent a high-fat challenge containing 60g butter. Blood samples were drawn before, and 1, 2, and 4h after the meal. Leukocyte reactive oxygen species (ROS) production, plasma MPO and MMP-9 activity, endothelial-derived soluble CD146 levels, and advanced oxidation protein product (AOPP) levels were determined. Human umbilical vein endothelial cells (HUVECs) were treated with human sera to evaluate mitochondrial membrane potential, ROS production, annexin PI staining, and caspase-3 activity. Triglycerides, ROS production, MPO activity, AOPP levels, pro-MMP-9 zymographic activity, and soluble CD146 levels significantly increased during the 4h after the test meal. Postprandial serum significantly decreased the mitochondrial membrane potential, and increased the rate of ROS production, the percentage of annexin-positive HUVECs, and caspase-3 activity. A strong relationship was observed between postprandial increase in PMN-derived MPO and pro-MMP-9 activity, and the increased rate of apoptosis of endothelial cells exposed to postprandial serum. Data show that postprandial serum exerts pro-apoptotic effects on endothelial cells. The close relationships between markers of endothelial cell apoptosis and MPO and pro-MMP-9 activity suggest that the latter may contribute to the development of fat meal induced endothelial damage.
Spallarossa
Paolo
P
Research Center of Cardiovascular Biology, Division of Cardiology, Department of Internal Medicine, University of Genova, Italy.
Garibaldi
Silvano
S
Barisione
Chiara
C
Ghigliotti
Giorgio
G
Altieri
Paola
P
Tracchi
Irene
I
Fabbi
Patrizia
P
Barsotti
Antonio
A
Brunelli
Claudio
C
D000328:Adult; D017209:Apoptosis; D050197:Atherosclerosis / Q000209:etiology*; D051929:CD146 Antigen / Q000097:blood; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D005223:Fats / Q000008:administration & dosage*; D005247:Feeding Behavior; D006801:Humans; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000502:physiology*; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology*; D010084:Oxidation-Reduction; D009195:Peroxidase / Q000502:physiology*; D019518:Postprandial Period; D011506:Proteins / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000097:blood / Q000378:metabolism; D044967:Serum / Q000737:chemistry*; D014280:Triglycerides / Q000097:blood
D051929:CD146 Antigen; D005223:Fats; D011506:Proteins; D017382:Reactive Oxygen Species; D014280:Triglycerides; D009195:Peroxidase; D020780:Matrix Metalloproteinase 9